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AbsTrACT
background Mitochondria provide aTP through 
the process of oxidative phosphorylation, physically 
located in the inner mitochondrial membrane (iMM). 
The mitochondrial contact site and organising system 
(MicOs) complex is known as the ’mitoskeleton’ due to 
its role in maintaining iMM architecture. APOO encodes 
Mic26, a component of MicOs, whose exact function 
in its maintenance or assembly has still not been 
completely elucidated.
Methods We have studied a family in which the most 
affected subject presented progressive developmental 
delay, lactic acidosis, muscle weakness, hypotonia, 
weight loss, gastrointestinal and body temperature 
dysautonomia, repetitive infections, cognitive impairment 
and autistic behaviour. Other family members showed 
variable phenotype presentation. Whole exome 
sequencing was used to screen for pathological variants. 
Patient- derived skin fibroblasts were used to confirm the 
pathogenicity of the variant found in APOO. Knockout 
models in Drosophila melanogaster and Saccharomyces 
cerevisiae were employed to validate Mic26 involvement 
in MicOs assembly and mitochondrial function.
results a likely pathogenic c.350T>c transition was 
found in APOO predicting an i117T substitution in 
Mic26. The mutation caused impaired processing of 
the protein during import and faulty insertion into the 
iMM. This was associated with altered MicOs assembly 
and cristae junction disruption. The corresponding 
mutation in Mic26 or complete loss was associated with 
mitochondrial structural and functional deficiencies in 
yeast and D. melanogaster models.
Conclusion This is the first case of pathogenic 
mutation in APOO, causing altered MicOs assembly and 
neuromuscular impairment. Mic26 is involved in the 
assembly or stability of MicOs in humans, yeast and flies.
INTroduCTIoN
Mitochondria are double- membrane organelles 
defining four compartments: the outer mitochon-
drial membrane (OMM); the intermembrane 
space; the inner mitochondrial membrane (IMM), 
containing the oxidative phosphorylation system 
(OXPHOS); and the matrix.1 The IMM is divided 
into two domains: the inner boundary membrane 
(IBM) and the cristae, which are connected by 
the cristae junctions (CJs).1 The CJs contain the 
mitochondrial contact site and organising system 
(MICOS).2 3 Mammalian MICOS complexes are 
composed of seven subunits: MIC60, MIC19, 
MIC10, MIC26, MIC27, MIC13 and MIC25. 
MIC60 and MIC19 in the mitochondrial inter-
membrane bridging (MIB) are in contact with the 
OMM. In the CJs, MIC60 and MIC10 play a domi-
nant role in cristae organisation.4
In mammals and Saccharomyces cerevisiae, 
two paralog MICOS subunits5 6 belong to the 
APOO family (APOOL/MIC27 and APOO/
MIC26). MIC26 was described to be glycosylated, 
producing a 55 kDa form found both inside the 
cells (Endoplasmic Reticulum and Golgi apparatus) 
and in the extracellular space, associated with 
cholesterol efflux7 and the non- glycosylated form 
of 22 kDa. The last one is present only in mito-
chondria, and its downregulation leads to mito-
chondrial morphology changes with a reduction in 
the number of CJs and reduced oxygen consump-
tion in HeLa cells.8
Defects in the MICOS system have been previ-
ously associated with mitochondrial disorders. In 
particular, pathogenic variants in MICOS13 (MIC13, 
QIL1 or C19ORF70), encoding a protein essential 
for MICOS assembly and function, are associated 
with childhood- onset encephalopathy and hepa-
topathy with combined mitochondrial respiratory 
chain deficiency.9–11 Mutations in CHCHD10, a 
MIC60- interacting protein,12 have been previously 
associated with clinical symptoms such as isolated 
myopathy, frontotemporal dementia and/or amyo-
trophic lateral sclerosis type II, and spinal muscle 
atrophy, Jokela type,13 with autosomal dominant 
inheritance. Even though no disease had been asso-
ciated with APOO defects, dysfunction of MICOS 
components and interactors are likely involved in 
a range of human diseases such as frontotemporal 
dementia–amyotrophic lateral sclerosis syndrome, 
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epilepsy, Parkinson’s disease, optic atrophy, cardiomyopathy and 
diabetes.14–16
Until this report, there were no known pathological variants in 
APOO causing mitochondrial disease. In this study, we describe 
a family carrying a c.350T>C pathogenic variant (p.I117T in 
MIC26) causing impaired processing of the mature form and 
binding to the IMM. Consequently, alterations in MICOS 
assembly and abnormalities in mitochondria ultrastructure were 
observed in patient- derived fibroblasts. The yeast MIC26 null 
strain showed slightly impaired growth under stress conditions, 
which was not rescued when the mutant protein was expressed, 
thus confirming the pathogenicity of p.I117T. The Drosophila 
melanogaster APOO ortholog (dApoO) was also shown to be 
essential for MICOS assembly, mitochondria cristae architecture 
and respiratory function.
MeThods
Molecular studies
DNA was extracted from blood using DNeasy Kit (Qiagen). 
Whole exome sequencing (WES) was carried out using Illumina 
2000 HiSeq and the GRCh37 reference genome, and a genome 
analysis toolkit, GATK- based pipeline was used to call, filter and 
annotate variants.17 Sanger sequencing was performed by Source 
BioScience, Cambridge, UK. SnapGene 4.3.3 (GSL Biotech LLC) 
was used for chromatogram visualisation and analysis. X- chro-
mosome inactivation using HpaII digestion was performed as 
previously described.18 Briefly, 400 ng of total blood isolated 
genomic DNA from females was incubated (37°C for 2 hour) 
with 4U of HpaII. After digestion of the active X chromosome, as 
HpaII is methylation- sensitive, the X- inactive chromosome was 
amplified by PCR sequenced as described previously. Pedigree 
was mounted using Pedigree Draw (Genial Genetic Solutions).
MrI
MRI of the brain were performed with a 1.5 T MR unit (Signa 
Explorer, GE Medical Systems). T1- weighted images (echo time 
(TE)/repetition time (TR) 11 ms/550 ms), T2- weighted images 
(TE/TR 93 ms/4000 ms), fluid- attenuated inversion recovery 
(FLAIR) (TE/TR/inversion time 110 ms/10 000 ms/2250 ms) 
and diffusion- weighted images (TE/TR: 105 ms/5200 ms) were 
obtained.
Cell culture
Fibroblasts were derived from patient skin and HeLa cells 
were obtained from ATCC (CCL-2), which were grown in 
high- glucose or galactose DMEM (Dulbecco's Modified Eagle 
Medium) supplemented with Glutamax, sodium pyruvate, 
10% FBS (fetal bovine serum), penicillin/streptomycin (Gibco 
Life Technologies) in humidified atmosphere at 37°C and 5% 
CO2. Immortalisation and cell rescue were performed by lenti-
viral infection (pLOX- Ttag- iresTK, Addgene plasmid #12246, 
pWPXLd- APOO- HA and pWPXLd- Ires- PuroR ‘empty vector’). 
Transfections were performed using Metafectene (Biontex).
S2R+ cells were grown at 25°C in Schneider’s medium 
(Thermo Fisher) with 10% FBS (Gibco). S2R+ cells were trans-
fected using Effectene (Qiagen).
TnT in vitro transcription/translation and in organello import
Transcription/translation was performed using the Promega TnT 
Quick Coupled System (L1170). The radiolabelled MIC26 prod-
ucts were used for the in organello import assays in mitochon-
dria from HeLa cells as described.19
Western blotting
Samples were lysed in TG buffer (Tris–HCl 20 mM, NaCl 
150 mM, EDTA 1 mM, Triton- X-100 1%, glycerol 10% and 
MgCl2 1.5 mM) with the addition of protease and phosphatase 
inhibitors. Lysates were centrifuged (6900×g, 10 min); superna-
tants were mixed with loading buffer and separated by sodium 
dodecyl sulfate–polyacrylamide gel electrophoresis (SDS- PAGE) 
prior to immunoblotting. Protein concentration was measured 
using the DC protein assay (Bio- Rad). Immunodetection signal 
intensities were quantified using ImageJ.20 The antibodies list is 
shown in online supplementary S1.1.
dephosphorylation of proteins
Cells were lysed in RIPA buffer (0.3 M NaCl, 0.1% SDS, 50 mM 
Tris, pH 7.4, 0.5% deoxycholate, 1 mM Na3VO4, 10 mM NaF, 
10 mM MgCl2, 1% n- dodecyl β-D- maltoside, 1 mM Phenyl-
methylsulfonyl fluoride or PMSF) with or without phosphatase 
inhibitors (Na3VO4, NaF, PMSF and PhosSTOP). For 400 µg of 
protein, 100 U of calf- intestinal alkaline phosphatase (CIP) was 
incubated for 30 min at 30°C in dephosphorylation buffer (5 mM 
Tris pH 7.9, 10 mM NaCl, 1 mM MgCl2 and 0.1 mM Dithioth-
reitol). The reaction was stopped by adding loading buffer.
Microscopy
Cells were fixed (3.7% formaldehyde in Phosphate- buffered 
Saline - PBS), permeabilised (0.1% Triton X-100, 0.05% sodium 
deoxycholate in PBS) and stained with primary and secondary 
antibodies (Invitrogen) in blocking solution (5% goat serum). 
Coverslips were mounted with ProLong Glass (Invitrogen). 
Confocal image acquisition was performed as described in 
online supplementary S1.2. Quantification of mitochondria 
interpuncta distance (IPD) was performed in aleatorily chosen 
regions in a blind way. Segmented lines were drawn across the 
mitochondria length connecting MIC60 dots. Profile of inten-
sities were plotted and distance was calculated from each peak 
manually using ImageJ.20
For transmission electron microscopy (TEM), fibroblasts were 
fixed (2.5% glutaraldehyde, 2% paraformaldehyde in 0.1 M PB 
buffer) for 1 hour. D. melanogaster heads and thoraxes were 
dissected in fixative and incubated on rotator overnight at 4°C. 
Cells were scraped and centrifuged (2500 RPM, 10 min, 4°C), 
and all the samples were washed with 0.1 M PB buffer. Samples 
were sent to the Electron Microscopy Platform (University of 
Barcelona, Spain) for sample preparation. Ultrathin sections 
(55 nm) were cut and mounted on 200 mesh copper grids with 
carbon support film. Image acquisition was performed with a 
transmission electron microscope (FEI Tecnai G2 Spirit) coupled 
with an CCD camera (Orius- SC200B, Gatan). Quantification 
was performed blindly and manually using ImageJ.20 For fibro-
blasts, 20 cells were analysed for each condition, and the number 
of cristae was counted per visible mitochondria area; maximum 
cristae width was determined by measuring randomly three to 
four cristae/mitochondrion and number of CJs counted per total 
of cristae. For flies, two samples were analysed specifically in 
the brain and muscle for each genotype. Maximum cristae width 
was determined by measuring randomly three to four cristae and 
the number of CJs per mitochondrion of 20 regions in the brain 
and 10 regions in the muscle.
o2 consumption measurements
Respiration in intact cells was measured using an Oxygraph‐2 k 
High Resolution Respirometer (Oroboros Instruments) as 
described.21
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blue native polyacrylamide gel electrophoresis (bN-PAGe) and 
in-gel activity (IGA)
Samples for BN- PAGE and IGA were prepared as described 
previously.22–24
Yeast model
The yeast haploid strain BY4741 Δmic26 (MATa his3Δ1 leu2Δ0 
met15Δ0 ura3Δ0 mic26::KanMX4) derived from the Euroscarf 
collection was used. Experiments were performed in synthetic 
complete (SC) medium (6.9 g/L yeast nitrogen base) without 
amino acids (ForMedium), 1 g/L drop‐out mix without amino 
acids or bases.25 Media were supplemented with carbon sources 
(Carlo Erba) in liquid phase or after solidification with 20 g/L 
agar. Plasmids were inserted using ‘LiAc/SS carrier DNA/PEG 
quick method’.26
Spot assays were performed on Petri dishes and pictures 
were taken after growth at 28°C. After 3 days of growth on SC 
medium supplemented with 5% ethanol, a picture of the second 
spot was taken at the microscope with a ×100 magnification. 
Diameter was measured only for colonies harbouring more than 
50 cells, corresponding to a diameter longer than 19.8 µm. For 
each strain, 100 colonies were measured on two independent 
clones.
Fly stocks and methods
Flies were raised on medium made of agar, cornmeal, molasses, 
propionic acid and yeast extract, and maintained at 25°C, on a 
12- hour light–dark cycle. The following strains were obtained 
from the Bloomington Drosophila Stock Centre w1118 (ID 6326), 
y[1] P{y[+mDint2] w[BR.E.BR]=SUPor P}amn[KG05433a] 
Hers[KG05433a]; ry[506] P{SUPor- P}CG5903[KG05433b] 
(ID: 14005). Line 14 005 was backcrossed with strain w1118 
in order to replace the X chromosome, carrying the allele 
KG05433a. The resulting line’s genotype is w1118; ry[506] 
P{y[+mDint2] w[BR.E.BR]=SUPor P}CG5903[KG05433b].
For lifespan assay, flies were reared at standard low density, 
collected after hatching, and divided into males and virgin 
females over a 24- hour window. Adults of the same sex were 
kept at a density of 10 per vial (for a total of 60 individuals) at 
25°C. Flies were counted and transferred to new tubes with fresh 
medium three times per week, without anaesthesia.
Climbing test was performed using a modified version of the 
countercurrent apparatus originally designed by Benzer27 as 
described previously.24
Mitochondria were prepared by differential centrifugation as 
previously described.24
statistical analysis
GraphPad Prism software was used, and tests as well as p value 
are described in the figure legends.
resulTs
Case report
Proband (figure 1A, IV1) is a male child aged 8 years, the oldest 
of two siblings from non- consanguineous parents. Clinical 
history included uneventful perinatal development, although he 
was born by caesarean delivery, weighing 3055 g and with a head 
circumference of 49 cm at birth, with no reported complications 
before or after birth. The mother (figure 1A, III2) presents tired-
ness, headaches and muscle weakness and had three pregnan-
cies with one previous miscarriage (at the sixth week). Brother 
and father were reported to be healthy. Several members of the 
family report muscle weakness, neurological problems and lactic 
acidosis.
The proband presented at 2 years with vomiting, fever and 
diarrhoea accompanied by progressive developmental delay, 
irritability, fatigue, hypotonia, weight loss, gastrointestinal and 
body temperature dysautonomia, repetitive infections, cognitive 
impairment and autistic behaviour. The first suspected diagnosis 
was autism spectrum disorder due to speech regression, hand 
stereotypies and flapping, with worsening of these symptoms 
during infections. Blood tests such as lactate and pyruvate were 
consistently elevated; venous blood examination showed severe 
metabolic acidosis and altered carnitine profile (increased C4, 
C5, C5:1, C5- OH), suggesting the possibility of a mitochondrial 
disease.
Brain MRI showed hyperintense signals in T2/FLAIR 
sequences in the white matter of the peritrigonal region, possibly 
corresponding to gliosis (figure 1B). The mother also presented 
hyperintense signals in T2/FLAIR in the white matter of the 
subcortical parietal frontal lobe (online supplementary figure 
S1A).
Treatment was started with L- carnitine, biotin and CoQ10, 
and was associated with normalisation of MRI, weight gain, 
decreased fatigue, irritability and autistic behaviour. The mother 
was also treated with good response to L- carnitine and CoQ10. 
The patient is currently undergoing reposition of immunoglob-
ulins with decreasing of repetitive infections and consequently 
improving general clinical presentation.
Genetic analysis
WES analysis of the proband DNA revealed the presence of a 
c.350T>C change in exon 5 of APOO, located in the Xp.22.11 
region, predicting a p.I117T missense change in the translation 
product MIC26. This variant was not found in control popula-
tion databases28 29 and was predicted to be likely pathogenic in 
mutation taster (score 1), provean (score −4.19) and vest3 (score 
0.924). The amino acid change is localised in the transmembrane 
region of the hydrophobic domain of the MIC26 (figure 1C).
The mother (III:2) was heterozygous for the c.350T>C variant 
(figure 1D) and the proband (IV:1) is hemizygous. Familial segre-
gation (online supplementary figure S1B) showed variability in 
clinical presentation, ranging from asymptomatic (figure 1A; II8, 
II10, III4, III6) to neuromuscular affectations like learning diffi-
culties and cognitive impairment (figure 1A; II2, II5, II6, IV1), 
fatigue and muscle weakness (figure 1A; II2, II5, II6, III2, III7, 
IV1) and increased blood lactate (figure 1A: IV7, IV1). Some 
females presented a clinical phenotype (figure 1A; III7, II6), but 
X- chromosome skewing pattern in blood cells was inconclusive 
in some cases, with affected females presenting random inacti-
vation (figure 1E and online supplementary figure S1B). In the 
case of the proband’s mother (figure 1D, III2), predominant acti-
vation of the mutant allele was observed (figure 1E, III2). Thus, 
leading to the conclusion of an X- linked recessive inheritance of 
this mutation.
Fibroblast characterisation
Analysis of MIC26 steady- state levels showed reduced levels and 
evident slower electrophoretic mobility of the mitochondrial 
22 kDa form in the immortalised proband- derived (P) fibroblasts 
(figure 2A). Differences in the glycosylated 55 kDa band were 
observed neither in P fibroblasts nor HeLa cells transfected with 
MIC26 small interfering RNA (siRNA) (online supplementary 
figure S1C).
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Figure 1 APOO mutation c.350T>c (p.i117T) shows an X- linked recessive inheritance pattern causing a range of phenotypes with affected females, 
depending on X- chromosome skewing. (a) Pedigree showing segregation of the c.350T>c mutation in APOO of the proband (indicated by arrow) family. 
Phenotypes are shown as *, # and %. (B) Brain Mri of proband showing hyperintense signal in the white matter. (c) schematic domains of Mic26 protein 
showing the position of possible MTs in n, aPOO domain (light grey) including the transmembrane domain where the mutation (i117T) is found. residue 
s162 is shown for O- glycosylation position of the non- mitochondrial form. (D) sequence chromatograms showing direct family members of proband with the 
mutation c.350T>c in heterozygosity in the mother (iii:2) and hemizygosity in the proband (iV:1). (e) sequence chromatograms showing the presence of the 
mutation in the skewed X- chromosome in the females (iii:4, iii:6, iii:7) and the complete inactivation of the normal allele in the proband mother (iii:2). *, 
muscle weakness; #, neurological problems; %, increased blood lactate; Flair, fluid- attenuated inversion recovery; MTs, mitochondrial targeting sequence; 
n, n- terminus.
To explore if the difference in size observed in the patient 
MIC2622Kda form was due to processing issues during mitochondrial 
import, we performed in organello import using both wild- type 
(WT) (MIC26_WT) and mutant (MIC26_I117T) radioactively 
labelled proteins (figure 2B). This assay revealed that the both WT 
and mutant mature proteins (*) are obtained through a double 
cleavage of the precursor proteins (#) during membrane potential- 
dependent import, showing the appearance of an intermediate 
product (**). However, the processing of the MIC26_I117T was 
different from that of the WT, giving rise to intermediate and 
mature species running noticeably slower than those from MIC26_
WT (apparent molecular sizes of 20.6 vs 19.1 kDA and 18.5 vs 
17.8 kDa, respectively). These observations explain why MIC26 
in the P cells displayed slower electrophoretic mobility (figure 2A). 
However, there were no differences in the mitochondrial localisa-
tion of MIC26- HAWT and mutant MIC26- HAI117T shown by super- 
resolution microscopy (figure 2C). When an HA- tagged version 
of the protein was overexpressed in the patient cells (PMIC26- HA+), 
the intermediate processing band (**) became evident (figure 2D). 
This was specific to the import process, as these processed products 
were not detected when dissipating the membrane potential with 
the uncoupler carbonyl cyanide 3- chlorophenylhydrazone - CCCP 
(figure 2B and online supplementary figures S1D,S1E). In these 
conditions, the cells accumulated the precursor in the cytoplasm 
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Figure 2 Mic26i117T binds weakly to the inner membrane due to incorrect precursor processing. (a) sDs- Page for Mic26 and gaPDh showing the 
cytosolic (55 kDa) and mitochondrial (22 kDa) Mic26 isoforms in ctrls (c1, c2 and c3) and P. representative image of five biological replicates. (B) TnT 
and in vitro organelle import of Mic26 WT and mutant showing # and two imported processed forms (* and **). representative image of two biological 
replicates. (c) representative n- siM micrographs of hela cells expressing Mic26WT- ha or Mic26i117T- ha labelled with anti- ha and anti- TOMM20 
antibodies. Maximum intensity projection is shown. scale bars: 5 µm, inset: 1 µm. representative image of three biological replicates. (D) sDs- Page blotted 
for ha and Mic26 showing ctrl, PeV, overexpressing Mic26 WT (PMic26- ha+) and rabbit reticulocytes lysates after in vitro transcription/translation of Mic26 
WT (TnTMic26- ha_WT) and mutant (TnTMic26- ha_i117T). cytoplasmic #, ** and *. (e) sDs- Page for P- DrP1 (s616), DrP1, Mic26 and gaPDh in total lysates 
treated with (+) or without (−) phosphatase inhibitors and akaline phosphatase from fibroblasts: ctrl, PeV (expressing empty vector), PMic26- ha (Mic26- 
ha WT – low levels), PMic26- ha+ (Mic26- ha WT high levels), representative image of two biological replicates. (F) sDs- Page for ha, cO1 and acO2 from 
different mitochondrial fractions (sol and memb) of hela cells overexpressing Mic26- haWT and Mic26- hai117T. representative image of two biological 
replicates. gaPDh, glyceraldehyde-3- phosphate dehydrogenase; MW, molecular weight; #, non- imported precursor; *, intermediate form; **, mature form; 
cccP, carbonyl cyanide 3- chlorophenylhydrazone; ha, human influenza hemagglutinin; n- siM, nikon structured illumination microscope; Memb, membrane 
bound; sol. soluble; ctrl, control; P, proband fibroblast; PeV, P fibroblasts expressing empty vector; sDs- Page, sodium dodecyl sulfate–polyacrylamide gel 
electrophoresis.
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and were visible when inhibiting the proteasome with epoxomicin 
(online supplementary figure S1E).
Another interesting observation was that when synthesising 
in vitro the MIC26WT and MIC26I117T precursors with and 
without HA tag, we observed a slightly slower electrophoretic 
mobility of the mutant protein (figure 2B,D and online supple-
mentary figure S1D). We hypothesised that the difference in the 
precursor size could be due to the presence of a phosphorylation 
site in T117, which is predicted by NetPhos30 V.3.1 and PPS.31 
However, the incubation of cell lysates from the patient fibro-
blasts with alkaline phosphatase did not produce a change in the 
size of MIC26 (figure 2E). This result suggests that the altered 
electrophoretic mobility is not due to phosphorylation. The 
existence of post- translational modifications or conformational 
abnormalities induced by the I117T change may be interesting 
to analyse in the future.
Bioinformatics predictions (by THMM2.032 indicated disrup-
tion of the MIC26 transmembrane domain by the I117T change 
(online supplementary figure S1F), potentially impairing its asso-
ciation with the IMM. We tested this possibility by analysing 
the differential interaction of MIC26- HAWT and MIC26- HAI117T 
with the IMM. As shown in figure 2F, the mutated protein was 
clearly more sensitive to carbonate extraction, indicating a looser 
interaction with the IMM than the WT.
To test if this altered membrane association of MIC26I177T 
disrupts the localisation and assembly of MICOS, we measured 
the distribution of the MICOS subunit MIC60 using super- 
resolution microscopy (figure 3A and online supplementary 
figure S2A). The IPD between two consecutive puncta of 
MIC60 in the IBM was altered in the patient cells (figure 3B) 
and also when the mutant MIC26 was overexpressed in HeLa 
cells (online supplementary figure S2B). The expression of WT 
MIC26 in the patient cells (PMIC26- HA) rescued the IPD to control 
values (figure 3B). No differences in mitochondrial morphology 
in P fibroblasts grown in either glucose or galactose media were 
observed (online supplementary figure S2C). Likewise, except 
for MIC26, no major differences in the steady- state levels of the 
other tested MICOS subunits were observed (online supplemen-
tary figure S2D,S2E). Also, overexpression of MIC26 (online 
supplementary figure S2D) or depletion by siRNA in HeLa cells 
(online supplementary figure S2F) did not alter the levels of 
other MICOS components.
Next, we analysed the assembly status of MICOS by 
BN- PAGE (figure 3C) followed by second- dimension SDS- PAGE 
(figure 3D), which in control fibroblasts showed the presence of 
two main MICOS bands, the MIB complex at ~2000 kDa and 
the MICOS complex at ~700 kDa, as previously described.33 In 
contrast with the control samples, where MIC60 was found in 
both complexes but preferentially accumulated in the MICOS 
band, in P fibroblasts, MIC60 was found mainly incorporated 
into MIB (figure 3D). This alteration was specifically associated 
with the MIC26 mutation, as expression of the WT protein in 
P fibroblasts restored the normal complex distribution between 
MICOS and MIB (figure 3E and F). Moreover, excessive MIC26 
expression (PMIC26- HA+) also resulted in mislocalisation of the 
subunits (figure 3F). The importance of a correct level of MIC26 
for the proper assembly of the MICOS complex was corrobo-
rated by RNAi in HeLa cells, showing a similar pattern of 
MICOS subunit accumulation towards the MIB (online supple-
mentary figure S3A,S3B). These results suggest that a finely 
tuned equilibrium among the subunits is necessary to maintain 
the structure of MICOS.
To test whether the MICOS alterations resulted in abnor-
malities in the formation of cristae and CJs, we analysed 
mitochondrial ultrastructure in fibroblasts by TEM (figure 4A). 
P fibroblasts showed wider and fewer cristae and CJs per cristae 
than the controls or the rescued (PMIC26) cells (figure 4B). 
However, this did not produce a reduction in the steady- state 
levels of OXPHOS subunits (online supplementary figure S3C), 
although oxygen consumption rates were reduced in the P cells 
grown in galactose (figure 4C) but not in glucose (figure 4D).
Yeast model
Yeast is a rapid and efficient tool to study the consequences of 
single point mutations, which can be easily introduced and stable 
maintained. S. cerevisiae has two orthologs of APOO, MIC26 
and MIC27, deriving from gene duplication.5 The I117 residue 
in human MIC26 protein corresponds to I127 in yeast Mic26 
and is highly conserved in all phyla/classes of opisthokonta 
except protozoa (online supplementary figure S4B).
In yeast, MICOS complex seems not to be fundamental for the 
oxidative growth and for the respiratory activity, since deletion 
of genes encoding four subunits, including Mic19 and Mic12, 
which do not have paralogs, and Mic26 and Mic27, has a slight 
effect or no effects on oxidative growth.2 34 Despite the mild 
phenotypical defects of the Δmic26 strain, yeast can be used 
experimentally to evaluate whether the mutant allele is able 
or not to rescue the phenotype. To evaluate the effects of this 
mutation in vivo, the null strain (Δmic26) was transformed with 
a single copy vector harbouring MIC26WT or mic26I127T. The 
strains were spotted on different carbon sources (online supple-
mentary figure S4A). The growth of the Δmic26EV was slightly 
decreased compared with the rescue Δmic26WT strain on the SC 
medium, with or without Na- lactate 2% when supplemented 
with ethanol 5%, the latter being used as a common means to 
induce stress. The growth difference between Δmic26EV and 
Δmic26WT strain was not visible from whole spots, but magni-
fication of single colonies from SC medium supplemented with 
5% ethanol after 3 days of growth and measurement of their 
diameter showed significantly smaller colonies in the Δmic26EV 
strain (figure 5A). On the contrary, colonies from Δmic26I127T 
strain showed a mean diameter which was not statistically signif-
icant from that of the Δmic26EV strain (figure 5A), indicating that 
the mutant allele is not able to rescue the phenotype of the null 
strain at all.
Fly model
Once proven that the mutant allele behaved like a null allele 
in yeast, we studied the effects on a D. melanogaster lacking 
the single APOO ortholog present in the fly genome (CG5903, 
hereafter named dApoO and dMic26 protein). dMic26 shares 
a sequence identity of 32% and 28% to MIC26 and MIC27, 
respectively (online supplementary figure S4C). Expression 
of the HA- tagged form of dMic26 in Drosophila S2R+ cells 
showed mitochondrial localisation (figure 5B).
To analyse the effects of dApoO deficiency in flies, we 
exploited a loss- of- function allele (KG05433b) containing a 
>11 000 bp- long P{SUPor- P} element within the open reading 
frame of the first exon of dApoO (online supplementary figure 
S4D). In homozygous flies, dApoO mRNA levels were severely 
reduced (online supplementary figure S4E). Crossing of hetero-
zygous dApoO KO flies produced slightly altered Mendelian 
ratios in the progeny (online supplementary figure S4F), indi-
cating a mild effect of the lack of dApoO during the develop-
mental stages. Phenotypically, both male and female adult 
KO flies displayed age- related neuromotor dysfunction, with 
climbing indexes ranging between 53% and 70% of the control 
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Figure 3 Distribution of MiB and MicOs components is altered in patient fibroblasts. (a) n- siM super- resolution micrographs showing ctrl, P and 
PMic26- ha fibroblasts labelled with anti- Mic60 and anti- TOMM20 antibodies. maximum intensity projection for TOMM20 and a single Z- stack (0.1 µm) 
for Mic60 are shown. scale bars: 5 µm, inset: 1 µm. representative image of two biological replicates. (B) charts show histogram for iPD of Mic60 and 
mean±seM (n=150 from five different cells); one- way analysis of variance followed by Tukey’s multiple comparison, p<0.001***. (c) Bn- Page showing 
the distribution of MiB and MicOs complex immunoblotted for Mic60, Mic27 and Mic10 antibodies in ctrls (c1 and c2) and P fibroblasts. representative 
image of three biological replicates. (D) second- dimension Page from Bn of fibroblasts (ctrl and P) immunoblotted for Mic60, Mic27, Mic10 and Mic26 
antibodies. representative image of two biological replicates. (e) Bn- Page showing the distribution of MiB and MicOs complex immunoblotted for Mic10 
antibody in ctrl and proband (PeV, PMic26- ha and PMic26- ha+) fibroblasts. representative image of two biological replicates. (F) second- dimension Page from 
Bn immunoblotted for Mic60, Mic27, Mic19, Mic10 and ha antibodies. representative image of two biological replicates. n- siM, nikon structured 
illumination microscope; Bn- Page, blue native polyacrylamide gel electrophoresis; ctrl, control; ha, human influenza hemagglutinin; sDhB, succinate 
dehydrogenase iron- sulfur subunit; iPD, interpuncta distance; MiB, mitochondrial intermembrane bridging MicOs, mitochondrial contact site and organising 
system; P, proband fibroblast; PeV, P fibroblasts expressing empty vector.
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Figure 4 TeM analysis of patient samples showing altered number of cristae and cJs, and width of cristae. (a) representative TeM micrographs from 
ctrl and Ps (PeV and PMic26- ha) showing mitochondria ultrastructure. scale bars: 0.2 µm. representative images of two biological replicates. (B) charts show 
mean±seM (n=20) of number of cristae per mitochondrial area, cristae maximum width and number of cJs per cristae. One- way anOVa followed by Tukey’s 
multiple comparison shows significant differences (cristae number: ctrl vs P: **p=0.0065, P vs PMic26: **p=0.0022; cristae width: ctrl vs P: **p=0.0011, 
P vs PMic26: **p=0.0024; cJs per cristae: ctrl vs P: *p=0.0177, P vs PMic26: *p=0.0166). (c) charts show mean±seM (n=4 biological replicates) Ocr of 
cells grown in galactose and (D) glucose. Two- way anOVa followed by sidak’s multiple comparison shows significant differences in basal Ocr (ctrl vs PeV: 
*p=0.032, PeV vs PMic26: p=0.0042), oligomycin Ocr (ctrl vs PeV: **p=0.0037), maximum Ocr (PeV vs PMic26: **p=0.0015) for cells grown in galactose. 
anOVa, analysis of variance; cJ, cristae junction; ctrl, control; P, proband fibroblast; PeV, P fibroblasts expressing empty vector; TeM, transmission electron 
microscopy; Ocr, oxygen consumption rate.
at 2 days and between 21% and 36% at 10 days posteclosion 
(figure 5C). In addition, KO of dApoO led to a significant short-
ening of life span, causing median survival rates between 39% 
(males) and 44% (females) of control flies (figure 5D). The 
observed behavioural defects are associated with mitochondrial 
dysfunction, as KO mitochondria showed severe decrease of 
both CI- linked and CII- linked respiration (figure 5E).
Next, we analysed cristae morphology in the KO flies via TEM 
of thoracic muscle and brain mitochondria (figure 6A). Similar 
to human mitochondria, the number of CJs were significantly 
decreased and the cristae were wider (figure 6B). Additionally, 
blue native gel electrophoresis (BNGE) analysis revealed a 
drastic alteration in the amounts and electrophoretic pattern of 
dMic60 in the MICOS complex. As shown in figure 6C, dMic60 
was also found in two main complexes, MICOS (lower band) 
and MIB (upper band) in the controls, whereas the signal was 
barely detectable in dApoO KO and appeared at lower molecular 
weight spots (figure 6D).
Finally, the steady- state levels and enzymatic activities of the 
OXPHOS complexes I–V were considerably reduced in the 
dApoO KO flies (figure 6E–H), consistent with the observed 
respiratory deficiency.
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Figure 5 Yeast ∆mic26 strain and dApoO KO in Drosophila melanogaster showing growth and survival deficiencies, respectively. (a) cells grown for 
3 days on sc supplemented with 5% ethanol (×100 magnification). chart shows the mean±seM (n=100) of the colonies’ diameter (one- way analysis 
of variance followed by Bonferroni’s test, ***p<0.001). representative images of three biological replicates. (B) representative confocal micrographs of 
Drosophila s2r+ cells transiently expressing cg5903- ha. cells have been labelled with anti- atp5a (red) and anti- ha (green) antibodies. (c) climbing 
assay performed in w1118 (control) and dApoO KO flies. chart shows mean±95% ci, n=60 animals (Kruskal- Wallis with Dunn’s multiple comparisons test, 
****p<0.0001). (D) survival curves of w1118 and dApoO KO flies. statistical analysis was performed with log- rank (Mantel- cox) test (****p<0.0001). 
(e) Ocr measured in fly homogenates from w1118 and dApoO KO strains. state 3 mitochondrial respiration was stimulated, in the presence of aDP, by 
the addition of Proline, Malate and glutamate (PMg, complex i- linked substrates) and pMg+succinate (PMg+s, complex i- linked plus complex ii- linked 
substrates). leaK- respiration was measured through the enzymatic inhibition of aTP synthase with oligomycin. Maximal respiration was achieved adding 
the uncoupler cccP. non- mitochondrial respiration was measured by inhibiting complex i (with rotenone) and complex iii (with antimycin a). Data plotted 
represent mean±sD of four biological replicates, normalised by the protein concentration of the homogenates (unpaired t- test; *p<0.05, **p<0.01, 
***p<0.001). dApoO, Drosophila melanogaster APOO ortholog; cccP, carbonyl cyanide 3- chlorophenylhydrazone; Ocr, oxygen consumption rate; sc, 
synthetic complete.
dIsCussIoN
WES analysis of a family presenting a clinical phenotype compat-
ible with mitochondrial disease identified a c.350T>C variant 
in APOO, following an X- linked recessive inheritance pattern 
with different range of clinical presentations and severity. In the 
case of the female carriers, X- chromosome inactivation skewing 
was shown to play an important role in the presentation of the 
phenotypes. This same effect was seen in other X- linked diseases 
like G6PD deficiency,35 Rett,36 Alport syndrome37 and Fabry 
disease.38 Although the inactivation of the X chromosome is 
entirely random, not all women have a 50:50 ratio of cells with 
one or the other X chromosomes active. This is visible in the 
proband’s mother, who presented skewed inactivation of the 
WT allele. Other females presented balanced inactivation of the 
X chromosome in blood, and are either healthy or presented 
symptoms. A number of complex mechanisms during early 
embryogenesis in the regulation of inactivation and distribution 
to different tissues can lead to extremely skewed ratios in certain 
tissues (mosaicism), resulting in expression of the mutated 
gene affecting certain tissues resulting in the X- linked recessive 
disorder phenotype in females.39
To our knowledge, this is the first description of a patholog-
ical variant in APOO, encoding MIC26, a component of the 
MICOS complex associated with a mitochondrial syndrome 
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Figure 6 dMic26 participate in the formation of cristae architecture via MicOs complex. (a) representative TeM micrographs from Drosophila control 
(w1118) and dApoO KO brain and thorax muscles. scale bars: 0.2 µm. (B) charts show mean±seM of the number of cJs per mitochondria and cristae 
maximum width in the brain and muscle (n=34 for w1118, n=40 for Kg05433b from two biological replicates). Unpaired t- test shows significant differences 
for cJs/mitochondria: brain: **p=0.0039, muscle: ****p<0.0001; cristae max width: brain: ****p<0.0001, muscle: ****p<0.0001). (c) Bn- Page showing 
the distribution of MiB and MicOs complex immunoblotted for dMic60 antibody in control (w1118) and dApoO KO (Kg05433b) flies. representative image 
of two biological replicates. (D) second- dimension Page from Bn immunoblotted for dMic60 antibody. representative image of two biological replicates. 
(e) Bn- Page and (F) iga analysis of Mrc complexes in control (w1118) and dApoO KO (Kg05433b) flies densitometric quantification of the (g) Bn- Page 
and (h) iga bands normalised to the intensity of the mitochondrial outer membrane marker porin. charts show mean±sD of three biological replicates 
(unpaired t- test; *p<0.05, **p<0.01). Bn- Page, blue native polyacrylamide gel electrophoresis; cJ, cristae junction; iga, in- gel activity; MiB, mitochondrial 
intermembrane bridging MicOs, mitochondrial contact site and organising system; TeM, transmission electron microscopy; Mrc, mitochondrial respiratory 
chain; VDac, voltage- dependent anion- selective channel protein.
of variable severity within the same family. The clinical pheno-
types of the mitochondrial diseases can be very variable, having 
different presentations and severity degrees, even with the same 
mutation.40 It could be that mutations in APOO are no different 
in this respect from other mitochondrial syndromes, which is 
further complicated by the fact of its X- linked inheritance and 
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different X- inactivation patterns shown by the female members 
of the studied family. Null variants in MICOS13 (QIL1), 
encoding the only other direct MICOS component (MIC13) 
to date associated with mitochondrial disease, cause auto-
somal recessive oxidative phosphorylation deficiency type 37 
(COXPD37, MIM: 618329) characterised by severe encepha-
lopathy and liver disease, leading to death during early child-
hood.9–11 Similar to the APOO- mutated patient, even if the 
mitochondrial morphology was very affected in the patient 
fibroblasts, they did not show respiratory chain enzymatic defi-
ciencies or altered respiration.9–11 In the QIL1 cases, however, 
combined enzymatic defects were revealed in postmitotic tissues 
(skeletal muscle and liver).9–11 All the patients were clinically 
more severe than the APOO cases reported here, and we should 
consider the fact that MIC13 is a central MICOS subunit and its 
absence affects the stability of MIC26, MIC27 and MIC10,9 10 
whereas MIC26 is more of a peripherally associated MICOS 
component41 and its ortholog MIC27 is still present.8 Also, the 
APOO mutation reported here is a missense variant producing 
a protein that retains partial functionality, as opposed to the 
non- sense variants found in MICOS13. The I117T missense 
variant in MIC26 was associated with lower steady- state levels 
of the protein and an evident slower SDS- PAGE electropho-
retic mobility of the mitochondrial 22 kDa band. Most proteins 
imported to the inner compartments of mitochondria contain an 
N- terminal mitochondrial targeting sequence (MTS) cleaved off 
by specific peptidases.42 Comparison of the size of the protein 
expressed in vivo in cultured cells with the size of the precursor, 
as well as in organello import experiments, indicated the pres-
ence of such a cleavable signal peptide in MIC26, which could 
not be consistently or accurately predicted by bioinformatic 
tools such as Mitoprot II43 or Mitofates.44 Our experiments 
clearly indicated that MIC26 undergoes a two- step processing, 
with the appearance of an intermediate and a mature form, 
when imported inside the mitochondria. This is not a unique 
case as several precursor proteins are processed twice, first by 
the matrix processing peptidase (MPP) and then by Icp55 (Inter-
mediate cleaving peptidase) that removes a single amino acid or 
by Oct1 (octapeptidyl aminopeptidase) that removes an octapep-
tide.45 The size difference of the intermediate and the mature 
form is compatible with Oct1 processing after cleavage of the 
MTS by MPP. Interestingly, a major consequence of the p.I117T 
variant was the altered processing sites of MIC26 during its 
import inside mitochondria, since both the intermediate and 
mature forms of MIC26I117T showed evidently slower electro-
phoretic mobility than those from the WT protein. It is possible 
that the mutation could alter the conformation of the precursor 
and impair its correct processing. A similar situation has been 
described for mutations in frataxin, an iron chaperone located 
in the MM46 also cleaved in a two- step fashion, which impairs 
the interaction with MPP and results in slower processing rates 
of the mature form.47 48 Our conclusion is that the difference 
in apparent size of the mature shown by MIC26I117T compared 
with MIC26WT was due to altered processing by mitochondrial 
peptidases during the import process.
In addition, the mutation compromised the interaction of 
MIC26 with the IMM, as MIC26I117T was dissociated from 
the membranes more easily than MIC26WT after carbonate 
treatment. This is compatible with the fact that the I117 lies 
within the hydrophobic transmembrane domain between resi-
dues 108 and 118.8 MIC26 deficiency caused also an alteration 
in MICOS subunit distribution, shifting the balance between 
the MIB (bridging the IMM to the OMM) and the MICOS, 
located in the CJs.2 16 This altered pattern is most likely the 
cause of the aberrant IMM ultrastructure observed by TEM 
in the patient cells and the abnormal MIC60 spacing shown 
by super- resolution microscopy in patient fibroblasts and HeLa 
cells expressing MIC26I117T. These observations indicate that 
the MIC26I117T variant produces an aberrant oligomerisation of 
MIC60, which is critical to CJ formation,49 and consequently 
the altered localisation of the MICOS complex in relation to 
the CJs. However, the steady- state levels of the other MICOS 
components were not affected, which can again be explained 
by the fact that MIC26 is a peripheral component of MICOS41 
or because its ortholog MIC278 is playing a compensatory role. 
The presence of Mic27 in yeast and its absence in D. melan-
ogaster could explain why the MICOS and functional defects 
are much stronger in the dMic26 KO flies than in the S. cere-
visiae Δmic26 strain.7 34 In any case, the Δmic26 yeast strain 
showed defective growth in metabolic stress conditions, which 
were not rescued by the mutated allele, confirming that I127T 
(I117T in the human protein) mutation affects the activity of 
the protein.
In conclusion, this is the first description of a pathogenic 
variant in APOO associated with mitochondrial disease due to 
MICOS complex impairment, showing X- linked recessive inher-
itance in a family with multiple affected individuals.
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